These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1782993

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
    Imperato A, Di Chiara G.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):219-28. PubMed ID: 3761194
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T, Ohmori T, Koyama T.
    Brain Res; 1994 Apr 18; 643(1-2):276-81. PubMed ID: 7518327
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
    Heidbreder CA, Schenk S, Partridge B, Shippenberg TS.
    Synapse; 1998 Nov 18; 30(3):255-62. PubMed ID: 9776129
    [Abstract] [Full Text] [Related]

  • 30. [Effect of centrally administrated substance P on the brain mesolimbic system activity in rats as measured by microdialysis].
    Nikolaev SV, Lebedev AA, Bychkov EP, Obliapin AV, Dambinova SA, Shabanov PD.
    Ross Fiziol Zh Im I M Sechenova; 2003 Feb 18; 89(2):123-8. PubMed ID: 12710181
    [Abstract] [Full Text] [Related]

  • 31. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG, Arborelius L, Höök BB, Hacksell U, Svensson TH.
    J Neural Transm (Vienna); 1996 Feb 18; 103(5):541-54. PubMed ID: 8811500
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens.
    Preda S, Govoni S, Lanni C, Racchi M, Mura E, Grilli M, Marchi M.
    Neuropsychopharmacology; 2008 Apr 18; 33(5):1062-70. PubMed ID: 17581530
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Kariya K, Tanaka J, Nomura M.
    Brain Res; 1994 Sep 19; 657(1-2):1-6. PubMed ID: 7820607
    [Abstract] [Full Text] [Related]

  • 37. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
    Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E.
    Brain Res; 2000 May 19; 865(1):85-90. PubMed ID: 10814735
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.